Recent searches
    Trending searches
    JNJ logo Johnson & Johnson +
    Johnson & Johnson
    +
    Revenue breakdown by Products & Services
    Revenue breakdown by Geography

    Johnson & Johnson's Revenue by Segment

    In fiscal year 2024, Johnson & Johnson's revenue by segment (products & services) are as follows:

    • Innovative Medicine: $56.96 B
    • MedTech: $31.86 B

    Learn more about Johnson & Johnson’s Revenue by Geography

    Check out competitors to Johnson & Johnson in a side-by-side comparison.

    Explore additional financial metrics for Johnson & Johnson.

    Continue reading...

    The above chart shows Johnson & Johnson's revenue percentage share by segment (products and services).

    In fiscal year 2022, Johnson & Johnson's revenue by segment is as follows:

    • Consumer generated $14.64 B in revenue, representing 8.42% of its total revenue.
    • Innovative Medicine generated $52.56 B in revenue, representing 30.25% of its total revenue.
    • Medical Devices generated $27.06 B in revenue, representing 15.57% of its total revenue.
    • MedTech generated $27.43 B in revenue, representing 15.78% of its total revenue.
    • Pharmaceutical generated $52.08 B in revenue, representing 29.97% of its total revenue.

    The biggest segment for Johnson & Johnson is the Innovative Medicine, which represents 30.25% of its total revenue.
    The smallest segment for Johnson & Johnson is the Consumer, which represents 8.42% of its total revenue.

    The above chart shows Johnson & Johnson's revenue percentage share by segment (products and services).

    In fiscal year 2023, Johnson & Johnson's revenue by segment is as follows:

    • Innovative Medicine generated $54.76 B in revenue, representing 64.3% of its total revenue.
    • MedTech generated $30.40 B in revenue, representing 35.7% of its total revenue.

    The biggest segment for Johnson & Johnson is the Innovative Medicine, which represents 64.3% of its total revenue.
    The smallest segment for Johnson & Johnson is the MedTech, which represents 35.7% of its total revenue.

    The above chart shows Johnson & Johnson's revenue percentage share by segment (products and services).

    In fiscal year 2024, Johnson & Johnson's revenue by segment is as follows:

    • Innovative Medicine generated $56.96 B in revenue, representing 64.13% of its total revenue.
    • MedTech generated $31.86 B in revenue, representing 35.87% of its total revenue.

    The biggest segment for Johnson & Johnson is the Innovative Medicine, which represents 64.13% of its total revenue.
    The smallest segment for Johnson & Johnson is the MedTech, which represents 35.87% of its total revenue.
    Continue reading...

    Summary Table

    Products & Services (Percent Share) 2022 2023 2024
    Innovative Medicine 30.25% 64.3% 64.13%
    MedTech 15.78% 35.7% 35.87%
    Consumer 8.42% - -
    Medical Devices 15.57% - -
    Pharmaceutical 29.97% - -
    Total Revenue 100% 100% 100%

    The above chart shows the revenue trend of different segments of Johnson & Johnson.

    In fiscal year 2024, the Innovative Medicine generated the most revenue ($56.96 B), and the MedTech generated the least revenue ($31.86 B).

    The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • Innovative Medicine revenue increased 4.03% ($2.21 B) from $54.76 B (in 2023) to $56.96 B (in 2024).
  • MedTech revenue increased 4.79% ($1.46 B) from $30.40 B (in 2023) to $31.86 B (in 2024).
    • Continue reading...

    Summary Table

    Products & Services 2022
    Value Change
    		2023
    Value Change
    		2024
    Value Change
    Consumer $14.64 B - - - - -
    Innovative Medicine $52.56 B - $54.76 B
    4.18%
    		$56.96 B
    4.03%
    Medical Devices $27.06 B - - - - -
    MedTech $27.43 B - $30.40 B
    10.84%
    		$31.86 B
    4.79%
    Pharmaceutical $52.08 B - - - - -
    Total Revenue $173.77 B - $85.16 B
    50.99%
    		$88.82 B
    4.30%

    Related company

    Related

    Submit feedback to Bullfincher